Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors

Cancer Res. 1977 Jul;37(7 Pt 1):2138-46.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Bone Marrow / drug effects
  • Bone Marrow / pathology
  • Bone Marrow Cells
  • Cell Division / drug effects
  • Child
  • Cyclophosphamide / therapeutic use
  • Cytarabine / therapeutic use
  • Daunorubicin / therapeutic use
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Growth Substances / blood*
  • Humans
  • Leukemia, Myeloid / blood
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / metabolism
  • Leukemia, Myeloid / pathology
  • Male
  • Middle Aged
  • Remission, Spontaneous
  • Thymidine / metabolism

Substances

  • Antineoplastic Agents
  • Growth Substances
  • Cytarabine
  • Cyclophosphamide
  • Thymidine
  • Daunorubicin